INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 166
RESEARCH DOSSIER / NOT AN ENDORSEMENT

PrideRx

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Treatments That Actually Work' - stigma-free, discreet care; Fee covers doctor + meds + shipping 'no surprises'; free shipping; lowest-possible-price positioning with competitor price table (vs Ro, WW Clinic); 'FDA-Approved. Not Compounded. No Shortcuts.' - anti-compound stance; Free 1-year HereTV subscription ($95.88 value) with first prescription - LGBTQ media tie-in

Audienceread

Our read: LGBTQ+ adults (PrEP, Doxy-PEP, HereTV partnership, Pride branding), plus general sexual-health/ED/hair-loss consumers; weight-loss buyers wanting branded meds cash-pay

Pricing & termssnapshot

Weight-care fee $25 first month, then $99/month. Zepbound drug $299-$449/month, Wegovy pill from $149, Foundayo $149-$299, billed separately.

Clinical relationshipsnot_found

Unnamed 'US-licensed healthcare providers'/'our physicians'; PrideRx 'provides telehealth services only' - no medical group entity named

Pharmacy & fulfillmentverified

Manufacturer channels: LillyDirect for Zepbound and Foundayo; NovoCare for Wegovy pill. Manufacturer programs bill the drug separately from PrideRx membership.

Advertising snapshotsnapshot

15 Oct 2026 public Google/Meta/LinkedIn library checks, attributable examples and exclusions in channel rows. Generic keyword totals are not brand totals; copy/access gaps are explicit.

Founding yearpartial

Publicly described as a new venture in Oct 2025; exact formation date not established. Domain age is not company age.

Founderspartial

Stephen P. Jarchow, Paul Colichman and John Mongiardo, reported as founders of the new venture in Oct 2025.

Location & entity contextpartial

Hollywood, California, per Oct 2025 trade coverage. Exact operating office unverified. Legal arbitration venue is not headquarters.

Search visibility samplesnapshot

Title: Homepage - PrideRX; Meta description: NONE SET (no meta description tag found on homepage - SEO gap); Crawler snapshot: WordPress; disallows /wp-admin/ and intake-form paths

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.